<ARTICLE> 5 <CIK> 0000816284 <NAME> Celgene Corporation <MULTIPLIER> 1 <CURRENCY> U.S. Dollars <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-1998 <PERIOD-START> JAN-01-1999 <PERIOD-END> SEP-30-1999 <EXCHANGE-RATE> 1.000 <CASH> 14,324,499 <SECURITIES> 4,299,974 <RECEIVABLES> 3,059,067 <ALLOWANCES> (117,512) <INVENTORY> 2,072,272 <CURRENT-ASSETS> 24,316,827 <PP&E> 10,435,529 <DEPRECIATION> (8,352,317) <TOTAL-ASSETS> 27,088,771 <CURRENT-LIABILITIES> 7,081,820 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 171,516 <OTHER-SE> (13,812,724) <TOTAL-LIABILITY-AND-EQUITY> 27,088,771 <SALES> 15,063,644 <TOTAL-REVENUES> 16,796,144 <CGS> 2,076,457 <TOTAL-COSTS> 34,289,116 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 1,954,420 <INCOME-PRETAX> (18,935,733) <INCOME-TAX> 0 <INCOME-CONTINUING> (18,935,733) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (18,935,733) <EPS-BASIC> (1.12) <EPS-DILUTED> (1.12)